March 7, 2022
Evaxion Biotech Completes Recruitment for Phase 1/2a Clinical Trial for Skin Cancer Drug
Evaxion Biotech has now finalized recruitment for Phase 1/2a clinical trial of EVX-02 in adjuvant melanoma patients.
Pharmaceuticals, Biotechnology and Life Sciences
Author: Dino Mustafić
March 7, 2022
Centessa Pharmaceuticals Expands Management Team and Adds to Extensive Development Expertise
In this newly created role reporting to the CEO, Dr. Yver will be accountable for the company’s overall development strategy, including scientific, clinical and regulatory matters, and will continue to provide support to research and clinical development teams.
March 7, 2022
Pharmaceutical Companies to Support Ukrainian People
Some pharmaceutical companies are donating money to support people in Ukraine and are condemning the war and violence in Ukraine.…
March 7, 2022
Abbott to Donate $2M to Ukrainian People
Abbott stands with the international community condemning the war and the violence in Ukraine against its people, and calls for peace.
March 7, 2022
Ovoca Bio not Affected by Sanctions against Russia;
The Board of Ovoca Bio, an international biopharmaceutical company focusing on women’s health, has issued a statement in response to events in Ukraine and Russia.
March 7, 2022
Tollys and Gustave Roussy enter into new research agreement
Tollys has entered into a sponsored research agreement with Gustave Roussy.
March 6, 2022
Oncimmune Holdings in new commercial contract with 10 companies
Oncimmune Holdings has signed a commercial contract with a new top 10 global pharmaceutical company by revenue, initially focusing on the autoantibody profiling of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (“CIDP”).
March 3, 2022
Medix Biochemica Launches New Website Establishing it as the Ultimate IVD Raw Materials Supplier
Medix Biochemica has announced the launch of its refreshed and expanding brand to reflect both the exciting improvements to its offering…
March 3, 2022
Pfizer’s RSV Vaccine Candidate Receives Breakthrough Therapy Designation for US
Pfizer has announced that its respiratory syncytial virus (RSV) vaccine candidate, PF-06928316 or RSVpreF, received Breakthrough Therapy Designation from the…
March 3, 2022
Roche Announces Donation of Essential Medicines to Ukraine
Roche have announced an initial donation of essential medicines to Ukraine, after the country has been violently invaded by Russia.…